In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Snapshot: February Highlights

Executive Summary

A selection of articles you might have missed from February 2022, including exclusive interviews and a look at the gene editing pipeline.

You may also be interested in...



Ovid Therapeutics: Seeking Innovation In Epilepsy Treatment

Rising Leader Julia Tsai wants to see Ovid Therapeutics become a market leading epilepsy company that listens to the needs of patients and develops innovative drugs to treat a spectrum of epileptic indications and symptoms.

Synaffix’s Serial Dealmaker On ADC Platform Success And Expanding Into Gene Therapy

Anthony DeBoer, head of business development at Synaffix, joined the company in 2014 and has helped develop a platform technology business model in the antibody drug conjugate space, where Synaffix has become one of the leading technology providers enabling best-in-class therapeutic candidates.

In Vivo's 2023 Rising Leaders At A Glance

Top 30 leaders: see the list of industry influencers highlighted in the fourth edition of In Vivo's Rising Leaders series.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

IV125034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel